A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis

BACKGROUND: Azelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action of azelastine nasal spray,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Anne K, Zhu, Yifei, Steacy, Lisa M, Walker, Terry, Day, James H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655060/
https://www.ncbi.nlm.nih.gov/pubmed/23635091
http://dx.doi.org/10.1186/1710-1492-9-16
_version_ 1782269824339017728
author Ellis, Anne K
Zhu, Yifei
Steacy, Lisa M
Walker, Terry
Day, James H
author_facet Ellis, Anne K
Zhu, Yifei
Steacy, Lisa M
Walker, Terry
Day, James H
author_sort Ellis, Anne K
collection PubMed
description BACKGROUND: Azelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action of azelastine nasal spray, versus the oral antihistamines loratadine 10 mg and cetirizine 10 mg in the relief of the symptoms of SAR. METHODS: 70 participants, aged 18-65, were randomized to receive azelastine nasal spray, cetirizine, loratadine, or placebo after controlled ragweed pollen exposure in the EEU. Symptoms were evaluated using the total nasal symptom score (TNSS). The primary efficacy parameter was the onset of action as measured by the change from baseline in TNSS. RESULTS: Azelastine displayed a statistically significant improvement in TNSS compared with placebo at all time points from 15 minutes through 6 hours post dose. Azelastine, cetirizine, and loratadine reduced TNSS compared to placebo with an onset of action of 15 (p < 0.001), 60 (p = 0.015), and 75 (p = 0.034) minutes, respectively. The overall assessment of efficacy was rated as good or very good by 46% of the participants for azelastine, 51% of the participants for cetirizine, and 30% of the participants for loratadine compared to 18% of the participants for placebo. CONCLUSIONS: Azelastine’s onset of action for symptom relief was faster than that of cetirizine and loratadine. The overall participant satisfaction in treatment with azelastine is comparable to cetirizine and statistically superior to loratadine. These results suggest that azelastine may be preferential to oral antihistamines for the rapid relief of SAR symptoms.
format Online
Article
Text
id pubmed-3655060
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36550602013-05-16 A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis Ellis, Anne K Zhu, Yifei Steacy, Lisa M Walker, Terry Day, James H Allergy Asthma Clin Immunol Research BACKGROUND: Azelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action of azelastine nasal spray, versus the oral antihistamines loratadine 10 mg and cetirizine 10 mg in the relief of the symptoms of SAR. METHODS: 70 participants, aged 18-65, were randomized to receive azelastine nasal spray, cetirizine, loratadine, or placebo after controlled ragweed pollen exposure in the EEU. Symptoms were evaluated using the total nasal symptom score (TNSS). The primary efficacy parameter was the onset of action as measured by the change from baseline in TNSS. RESULTS: Azelastine displayed a statistically significant improvement in TNSS compared with placebo at all time points from 15 minutes through 6 hours post dose. Azelastine, cetirizine, and loratadine reduced TNSS compared to placebo with an onset of action of 15 (p < 0.001), 60 (p = 0.015), and 75 (p = 0.034) minutes, respectively. The overall assessment of efficacy was rated as good or very good by 46% of the participants for azelastine, 51% of the participants for cetirizine, and 30% of the participants for loratadine compared to 18% of the participants for placebo. CONCLUSIONS: Azelastine’s onset of action for symptom relief was faster than that of cetirizine and loratadine. The overall participant satisfaction in treatment with azelastine is comparable to cetirizine and statistically superior to loratadine. These results suggest that azelastine may be preferential to oral antihistamines for the rapid relief of SAR symptoms. BioMed Central 2013-05-01 /pmc/articles/PMC3655060/ /pubmed/23635091 http://dx.doi.org/10.1186/1710-1492-9-16 Text en Copyright © 2013 Ellis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ellis, Anne K
Zhu, Yifei
Steacy, Lisa M
Walker, Terry
Day, James H
A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title_full A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title_fullStr A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title_full_unstemmed A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title_short A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
title_sort four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655060/
https://www.ncbi.nlm.nih.gov/pubmed/23635091
http://dx.doi.org/10.1186/1710-1492-9-16
work_keys_str_mv AT ellisannek afourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT zhuyifei afourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT steacylisam afourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT walkerterry afourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT dayjamesh afourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT ellisannek fourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT zhuyifei fourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT steacylisam fourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT walkerterry fourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis
AT dayjamesh fourwaydoubleblindrandomizedplacebocontrolledstudytodeterminetheefficacyandspeedofazelastinenasalsprayversusloratadineandcetirizineinadultsubjectswithallergeninducedseasonalallergicrhinitis